SEATTLE, Feb. 22, 2024 Adaptive Biotechnologies Corporation , a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to.
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that
Revance Therapeutics, Inc. today announced that the company will be participating in the following investor conferences.
Cowen 44th Annual Healthcare Conference
Chief Executive Officer, Mark Foley.
Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present at and.
OmniAb, Inc. today announced that management will be participating in two upcoming investor conferences in March.
TD Cowen 44th Annual Healthcare Conference, March 4-6, 2024, at the Marriott.